期刊
ONCOLOGY LETTERS
卷 16, 期 1, 页码 157-166出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2018.8617
关键词
chimeric antigen receptor; programmed death-ligand 1; NCI-H358; A549
类别
资金
- National High Technology Research and Development Program of China [2014AA022206]
A chimeric antigen receptor (CAR) is a type of fusion protein that comprises an antigen-recognition domain and signaling domains. In the present study, a programmed death-ligand 1 (PD-L1)-specific CAR, comprised of a single-chain variable fragment (scFv) derived from a monoclonal antibody, co-stimulatory domains of cluster of differentiation (CD) 28 and 4-1BB and a T-cell-activation domain derived from CD3 zeta, was designed. The construction was cloned and packaged into the lentiviral vector pLVX. Flow cytometry confirmed that peripheral blood mononuclear cells were efficiently transduced and that the CAR was successfully expressed on T cells. The cytotoxicity of transduced T cells was detected using PD-Ll-positive NCI-H358 bronchioalveolar carcinoma cells and A549 lung adenocarcinoma cells (with a low expression of PD-L1, only in the A549 cells). The results demonstrated mild cytotoxicity at an effector-to-target ratio of 10:1. An ELISA revealed a significant increase in the level of interferon-y released from T cells transduced with scl: v-2813z when the cells were co-cultured with PD-L1-positive NCI-11358 cells, while interkeukin-2 and tumor necrosis factor-a levels remained unchanged. These data indicated a potential method for the treatment of solid tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据